Novel Markers, Glycemic Variability Predict CV Events in Diabetes

Slideshow

From ADA 2018: Two new biomarkers predict CV events independently of conventional risk factors, plus post-hoc analysis of VADT.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes / image credit Karolinska Institutet

Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes

Grace Halsey
September 17th 2025
Article
Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
September 17th 2025
Podcast
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

Grace Halsey
September 17th 2025
Article
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
September 17th 2025
Podcast
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Sydney Jennings
September 17th 2025
Article
FDA Clears First Over-The-Counter CGM for Weight Management From Signos / image credit ©lukszczepanski/stock.adobe.com

Signos Wins Clearance for First Over-The-Counter CGM for Weight Management

Grace Halsey
September 17th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.